Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
06/2002
06/13/2002US20020072586 Chiral peptide nucleic acids
06/13/2002CA2426988A1 Multicomponent compositions containing chitosan and methods of preparing same
06/12/2002EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/12/2002EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
06/12/2002EP0969843B1 Antitussive compositions containing theobromine
06/12/2002CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha
06/11/2002US6404433 Data-driven layout engine
06/11/2002US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology
06/11/2002CA2076886C Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor
06/06/2002WO2001093841A3 Barbituric acid analogs as therapeutic agents
06/06/2002US20020068745 Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereof
06/05/2002EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
06/05/2002EP1210347A1 Carbocyclic nucleosides and process for obtaining such
06/05/2002EP1210087A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
05/2002
05/30/2002WO2002042303A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
05/30/2002WO2001087235A3 Method for producing[18f]fluoride ion
05/29/2002EP1208100A1 Selective antagonists of a2b adenosine receptors
05/29/2002EP1208085A2 Benzanilides as potassium channel openers
05/29/2002EP1070076A4 Chiral separations of pyrimidines
05/29/2002EP0736027B1 Guanine synthons for peptide nucleic acid synthesis and method for production
05/29/2002EP0698607B1 Xanthine derivative
05/29/2002CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002CA2165433C Novel chemical compounds having pde-iv inhibition activity
05/28/2002CA2088363C Process for the preparation of nucleotides
05/28/2002CA2038747C Selective adenosine receptor agents
05/23/2002WO2002040481A2 Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions and method of use thereof
05/23/2002US20020061899 Administering to patient with drug-induced peripheral neuropathy an effective quantity of a purine derivative or analogue, a tetrahydroindolone derivative or analogue, or a pyrimidine derivative or analogue
05/23/2002US20020061897 Neuropeptide Y antagonists
05/23/2002US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative
05/22/2002CN1350535A Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
05/21/2002US6392085 Therapeutic nucleosides
05/21/2002US6392049 Nitration using nitric acid
05/16/2002WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/16/2002US20020058816 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/ reproductive disorders, depression
05/16/2002US20020058704 Multicomponent compositions containing chitosan and methods of preparing same
05/16/2002US20020058671 Neuropeptide Y antagonists
05/16/2002US20020058670 Glycosylating purine or pyrimidine base low temperature with an intermediate to for producing a beta -nucleoside analogue
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use
05/15/2002CN1084622C 药物 Drug
05/14/2002US6388074 Process for the preparation of purine derivatives
05/14/2002US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
05/14/2002US6387922 Annulated azole derivatives useful as microbicidal agents
05/10/2002WO2002036075A2 Small molecule compositions for binding to hsp90
05/10/2002WO2001028545A3 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
05/10/2002WO2001023389A3 Certain alkylene diamine-substituted heterocycles
05/10/2002WO2000053603A9 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents
05/09/2002US20020055506 Methods for treatment of disease-induced peripheral neuropathy and related conditions
05/08/2002EP1202628A1 Novel hypoxanthine and thiohypoxanthine compounds
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/07/2002US6384039 QT dispersion and heart rate variability improvement with CRF antagonists to prevent sudden death
05/02/2002WO2001090121A3 Methods and compositions for treating hepatitis c virus
05/02/2002WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
05/02/2002US20020052721 Data driven layout engine
05/02/2002US20020052492 Process for the production of 2-halo-6-aminopurine derivatives
05/02/2002US20020052393 Benzanilides as potassium channel openers
05/02/2002EP1200435A1 Purine derivatives inhibitors of tyrosine protein kinase syk
05/02/2002EP0804199B1 Use of penciclovir for the treatment of post herpetic neuralgia
04/2002
04/30/2002US6380221 Ortho-anthranilamide derivatives as anti-coagulants
04/25/2002WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
04/25/2002WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
04/25/2002WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
04/25/2002US20020049218 2-, 6, and 9-substituted purine derivatives, particularly 2(1-R hydroxymethylpropylamino)-6-benzylamino-9-isopropyl purine, used as drug and herbicide; inhibiting effect with respect to cyclin-dependent kinase proteins
04/25/2002US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors
04/25/2002US20020049207 Nitrogen containing heterobicyclic compounds for treating disorders manifesting hypersecretion of corticotropin releasign factor(CRF) in a warm-blooded animals, such as stroke
04/25/2002US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
04/25/2002CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis
04/24/2002EP1198464A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES
04/24/2002EP0628311B1 Xanthine-Derivatives as Antidepressants
04/24/2002CN1346356A 治疗性的核苷化合物 Therapeutic nucleoside compound
04/24/2002CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
04/23/2002US6376501 Type 2 helper T cell-selective immune response suppressors
04/23/2002US6376472 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
04/18/2002WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002CA2425359A1 Dioxolane analogs for improved inter-cellular delivery
04/17/2002EP1196416A1 Substituted purine derivatives as inhibitors of cell adhesion
04/17/2002EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002CN1082816C Use of penciclorim for treatment of post-therapeutic neuralgia
04/16/2002US6372767 Benzanilides as potassium channel openers
04/16/2002US6372740 2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof
04/11/2002WO2002028820A1 Nitroso diphenylamine derivatives
04/11/2002WO2002028808A1 Triptycene analogs
04/11/2002US20020042424 Viricides
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/10/2002EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity
04/10/2002EP0936911B1 Adenosine deaminase inhibitors
04/10/2002EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom
04/10/2002CN1344266A Novel compounds
04/09/2002US6369066 Substituted 1,3-oxathiolanes with antiviral properties
04/04/2002US20020040032 Methods for stimulation of synthesis of synaptophysin in the central nervous system
04/04/2002US20020040031 Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
04/03/2002EP1193257A2 Compounds for ceramide-mediated signal transduction
04/03/2002EP1192170A1 Propargyl phenyl ether a2a receptor agonists
04/03/2002EP1192158A2 Substituted 8-phenylxanthines useful as antagonists of a 2b? adenosine receptors
04/03/2002CN1342651A Ganciclovir sodium hydrate and its preparing process and application
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 120